|
Bharat Immunological & Biologicals Corporation Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
102.38 Cr.
|
P/BV
|
1.17
|
Book Value (Rs.)
|
20.33
|
|
52 Week High/Low (Rs.)
|
36/19
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
29/12/2023
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | -3.95 | -2.03 | -4.19 | -2.36 | -1.57 |
| Diluted EPS (Rs.) | -3.95 | -2.03 | -4.19 | -2.36 | -1.57 |
| Cash EPS (Rs.) | -3.92 | -1.98 | -4.14 | -2.31 | -1.28 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 20.33 | 24.40 | 7.88 | 4.74 | 7.10 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 20.33 | 24.40 | 7.88 | 4.74 | 7.10 |
| Revenue From Operations / Share (Rs.) | 10.33 | 18.15 | 19.76 | 15.48 | 19.37 |
| PBDIT / Share (Rs.) | -3.63 | -0.89 | -4.45 | -2.14 | -1.18 |
| PBIT / Share (Rs.) | -3.66 | -0.94 | -4.50 | -2.19 | -1.24 |
| PBT / Share (Rs.) | -5.29 | -2.24 | -5.61 | -3.29 | -1.71 |
| Net Profit / Share (Rs.) | -3.95 | -2.03 | -4.19 | -2.36 | -1.34 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | -35.11 | -4.95 | -22.49 | -13.80 | -6.08 |
| PBIT Margin (%) | -35.44 | -5.22 | -22.76 | -14.15 | -6.41 |
| PBT Margin (%) | -51.22 | -12.35 | -28.36 | -21.25 | -8.81 |
| Net Profit Margin (%) | -38.23 | -11.16 | -21.22 | -15.27 | -6.92 |
| Return on Networth / Equity (%) | -19.42 | -8.30 | -53.20 | -49.87 | -18.88 |
| Return on Capital Employeed (%) | -16.78 | -3.67 | -48.70 | -36.22 | -14.71 |
| Return On Assets (%) | -9.18 | -4.11 | -17.41 | -8.05 | -4.63 |
| Total Debt / Equity (X) | 0.79 | 0.73 | 0.80 | 0.14 | 1.05 |
| Asset Turnover Ratio (%) | 0.22 | 0.49 | 0.73 | 0.53 | 0.93 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.36 | 0.64 | 0.52 | 0.92 | 1.12 |
| Quick Ratio (X) | 0.34 | 0.28 | 0.31 | 0.41 | 0.95 |
| Inventory Turnover Ratio (X) | 1.75 | 2.38 | 1.87 | 2.08 | 10.43 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | -2.22 | -0.69 | -4.02 | -1.95 | -2.54 |
| Interest Coverage Ratio (Post Tax) (%) | -1.42 | -0.56 | -2.79 | -1.15 | -1.89 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 157.30 | 186.21 | 213.23 | 16.07 | 57.50 |
| EV / Net Operating Revenue (X) | 3.53 | 2.38 | 2.50 | 0.24 | 0.68 |
| EV / EBITDA (X) | -10.04 | -47.96 | -11.11 | -1.74 | -11.29 |
| MarketCap / Net Operating Revenue (X) | 2.15 | 1.55 | 2.30 | 0.37 | 0.39 |
| Price / BV (X) | 1.09 | 1.15 | 5.77 | 1.23 | 1.08 |
| Price / Net Operating Revenue (X) | 2.15 | 1.55 | 2.30 | 0.37 | 0.39 |
| EarningsYield | -0.17 | -0.07 | -0.09 | -0.40 | -0.17 |
